Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Feb;21(2):231-5.

The leukopoietic cytokine granulocyte colony-stimulating factor increases blood flow to rat bone marrow

Affiliations
  • PMID: 7678810

The leukopoietic cytokine granulocyte colony-stimulating factor increases blood flow to rat bone marrow

P O Iversen et al. Exp Hematol. 1993 Feb.

Abstract

The current knowledge concerning the blood supply to hematopoietic bone marrow during increased marrow metabolism is scanty. We have previously shown that an accelerated erythropoiesis in the awake rat is accompanied by a rapid increase in perfusion of the tibial marrow and its bony encasement. We have now measured blood flow to tibial marrow and bone in rats with stimulated granulopoiesis, caused by injection of recombinant human granulocyte colony-stimulating factor (rhG-CSF). In awake, adult rats, blood flow was measured with the microsphere method before and at intervals during a 48-hour period after subcutaneous (s.c.) injection of rhG-CSF (10 micrograms/kg). Administration of rhG-CSF caused a marked leukocytosis, mostly due to an increase in blood granulocytes, amounting to 4 times the control value at 8 hours. Concomitantly, the perfusion of tibial marrow rose to about 200% of control by 8 hours before it declined toward baseline. Denervation of the marrow had no effect on this hyperemic response. The perfusion of tibial bone was apparently unaffected by rhG-CSF injection. We conclude that rhG-CSF injection increases blood flow to hematopoietic marrow, but not to bone. This may have important implications for marrow transplantation and drug therapy for patients with marrow failure.

PubMed Disclaimer

Similar articles

Publication types

Substances